Vik Chopra
Stock Analyst at Wells Fargo
(2.73)
# 1,880
Out of 4,784 analysts
36
Total ratings
33.33%
Success rate
3.21%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Maintains: Equal-Weight | $73 → $75 | $74.75 | +0.33% | 3 | Feb 28, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $20 → $19 | $14.93 | +27.26% | 2 | Feb 28, 2025 | |
| MASI Masimo | Maintains: Overweight | $193 → $205 | $163.55 | +25.34% | 8 | Feb 26, 2025 | |
| GMED Globus Medical | Maintains: Overweight | $95 → $93 | $72.55 | +28.19% | 9 | Feb 21, 2025 | |
| ALGN Align Technology | Initiates: Overweight | $255 | $159.21 | +60.17% | 1 | Feb 14, 2025 | |
| HSIC Henry Schein | Initiates: Equal-Weight | $80 | $68.62 | +16.58% | 1 | Feb 14, 2025 | |
| CNMD CONMED | Maintains: Equal-Weight | $74 → $70 | $58.85 | +18.95% | 3 | Feb 6, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $20 → $21 | $16.97 | +23.75% | 2 | Feb 6, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $15 → $13 | $11.85 | +9.70% | 2 | Nov 13, 2024 | |
| ATEC Alphatec Holdings | Maintains: Overweight | $26 → $19 | $10.19 | +86.46% | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $45 → $25 | $21.69 | +15.26% | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $79 | $37.76 | +109.22% | 3 | Feb 23, 2024 |
Solventum
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $73 → $75
Current: $74.75
Upside: +0.33%
DENTSPLY SIRONA
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $14.93
Upside: +27.26%
Masimo
Feb 26, 2025
Maintains: Overweight
Price Target: $193 → $205
Current: $163.55
Upside: +25.34%
Globus Medical
Feb 21, 2025
Maintains: Overweight
Price Target: $95 → $93
Current: $72.55
Upside: +28.19%
Align Technology
Feb 14, 2025
Initiates: Overweight
Price Target: $255
Current: $159.21
Upside: +60.17%
Henry Schein
Feb 14, 2025
Initiates: Equal-Weight
Price Target: $80
Current: $68.62
Upside: +16.58%
CONMED
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $74 → $70
Current: $58.85
Upside: +18.95%
Envista Holdings
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $20 → $21
Current: $16.97
Upside: +23.75%
NeuroPace
Nov 13, 2024
Maintains: Overweight
Price Target: $15 → $13
Current: $11.85
Upside: +9.70%
Alphatec Holdings
Aug 1, 2024
Maintains: Overweight
Price Target: $26 → $19
Current: $10.19
Upside: +86.46%
May 7, 2024
Downgrades: Equal-Weight
Price Target: $45 → $25
Current: $21.69
Upside: +15.26%
Feb 23, 2024
Maintains: Overweight
Price Target: $73 → $79
Current: $37.76
Upside: +109.22%